Pioneering Pharma/IT deals target outcomes

Drugmakers are cozying up to IT companies to better make the case for their products. "This movement will be driven by a focus on outcomes," says Patrick Flochel of Ernst & Young. Novartis, for example, is working on "smart pills" that transmit data from inside the body to monitor patients' vital signs and check whether they have taken medicines as prescribed. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.